Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, M. Juliana McElrath, Lu Zhang et al.|The Journal of Infectious Diseases|2022Cited by 50
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, M. Juliana McElrath, Janine van Duijn et al.|EBioMedicine|2024Cited by 17
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responsesOne Dintwe, Erica Andersen‐Nissen, Stephen C. De Rosa et al.|Journal of Leukocyte Biology|2022Cited by 2
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, M. Juliana McElrath, One Dintwe et al.|Zenodo (CERN European Organization for Nuclear Research)|2022Cited by 0
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320Avi Kenny, M. Juliana McElrath, Janine van Duijn et al.|EBioMedicine|2025Cited by 0